New MS Drug Kesimpta May Help Keep Symptoms at Bay

THURSDAY, July 18, 2024 -- A new monoclonal antibody treatment called Kesimpta (ofatumumab) appears to improve on an older drug in pushing multiple sclerosis (MS) into remission, a new trial shows.

Funded by Kesimpta's maker, Novartis, the trial...